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Virus–vector interactionsf West Nile virus (WNV) contain a single N-linked glycosylation site on their
envelope (E) proteins. Previous studies have shown that E-glycosylated strains are more neuroinvasive in
mice than non-glycosylated strains. E protein glycosylation also appears to play a role in attachment and
entry of WNV into host cells in vitro; however, studies examining how E protein glycosylation affects the
interactions of WNV with its mosquito vectors in vivo have not yet been performed. We mutated the E
protein glycosylation site from NYS to IYS in a previously described full-length clone of the NY99 genotype of
WNV (WT), resulting in a virus that lacked the glycan at aa154. WNV-N154I replicated less efﬁciently than
WNV-WT in Culexmosquito tissues, although the extent of the decrease was greater in Cx. pipiens than in Cx.
tarsalis. Following peroral infection, mosquitoes infected with WNV-N154I were less likely to transmit virus
than those infected with WNV-WT. Interestingly, all but one of the mosquitoes infected with WNV-N154I
transmitted a revertant virus, suggesting that there is strong selective pressure toward E protein
glycosylation. Together these data suggest that loss of the glycan at aa154 on the WNV E protein can
severely restrict viral spread in the mosquito vector.
© 2009 Elsevier Inc. All rights reserved.IntroductionWest Nile virus (WNV) is a member of the Japanese encephalitis
virus (JEV) serocomplex of the Flavivirus genus (family Flaviviridae)
(Gubler et al., 2007; Lindenbach et al., 2007). Other members of this
genus include the mosquito-borne viruses St. Louis encephalitis virus
(SLEV), Dengue virus (DENV), and Yellow fever virus (YFV), as well as
tick-borne viruses such as Tick-borne encephalitis virus (TBEV) and
other viruses that do not appear to be transmitted by an insect vector.
WNV is maintained in nature via an enzootic transmission cycle
between Culex mosquito vectors and avian reservoir hosts. Although
periodic outbreaks occur in horses and humans, infection of mammals
does not appear to contribute substantially to the maintenance of
WNV in nature (Weaver and Barrett, 2004). Of the two main lineages
of WNV, lineage 1 has the larger geographic range and includes the
viruses currently circulating in the Americas (Gubler et al., 2007).
Viruses in this lineage are generally more pathogenic and can lead to
severe central nervous system infection and death. Lineage 2 viruses
are found only in sub-Saharan Africa and Madagascar; infection with
WNV belonging to this lineage rarely progresses to severe disease in
humans.dy).
ll rights reserved.WNV contains a conserved N-linked glycosylation site in the prM
envelope protein. This glycosylation site is located within the
ectodomain of prM that is cleaved by cellular enzymes during viral
particle maturation. The prM proteins of ﬂaviviruses form hetero-
dimers with the viral envelope (E) protein (Zhang et al., 2003) and
appear to act as chaperones for correct and efﬁcient folding of E
protein (Konishi and Mason, 1993; Lorenz et al., 2002; Ocazionez
Jimenez and Lopes da Fonseca, 2000). Studies with WNV and TBEV
have found that deletion of the N-linked glycosylation site in prM led
to a decrease in virus release (Goto et al., 2005; Hanna et al., 2005).
These results suggest that prM glycosylation may be required for
efﬁcient particle assembly, possibly due to a requirement for
glycosylated prM as a chaperone for E protein folding. However, the
precise role of prM glycosylation in particle assembly has not yet been
elucidated.
In contrast to the conserved glycosylation of prM protein, WNV E
protein is not universally glycosylated. Many strains possess an N-
linked glycosylation site at aa position 154, while others contain
mutations at aa154 or aa156, or a four aa deletion, that ablate this site
(Adams et al., 1995; Berthet et al., 1997; Davis et al., 2005; Ebel et al.,
2004; Lanciotti et al., 2002). Many other ﬂaviviruses also contain a
glycosylation site in this region of the E protein (Ryman et al., 1997).
Interestingly, it was noted that many of the major outbreaks of human
diseasewere caused by strains containing this glycosylation site (Hanna
et al., 2005). Studies in mice have found that although the E-
Fig. 1. Effect of N154I mutation on WNV E protein glycosylation. WNV-WT and WNV-
N154I viruses were incubated with PNGase F (+) or buffer only (−). Viral E proteins
were visualized by Western blot using an anti-E MAb.
223R.M. Moudy et al. / Virology 387 (2009) 222–228glycosylated and non-glycosylated strains of WNV are equally neuro-
virulent, viruses containing the E protein glycosylation site are more
neuroinvasive (Beasley et al., 2005; Shirato et al., 2004). Deletion of the
glycosylation site in the TBEV or WNV E proteins resulted in
substantially decreased viral particle release from mammalian cells
(Goto et al., 2005; Hanna et al., 2005). However, particle infectivity wasFig. 2. Replication efﬁciencies of WNV-WT and WNV-N154I in vitro. Conﬂuent cells were inf
were taken at the indicated times for virus titration in Vero cells. Viral titers at each time pincreased threefold for mammalian and avian cells and 30-fold for
mosquito cells when WNV lacked the glycosylation site (Hanna et al.,
2005). It is interesting to speculate that differentially glycosylatedWNV
may not be equally infectious for or transmitted equally by their
mosquito vectors or avian reservoir hosts. In the current study, we
examined the effect of E protein glycosylation on the interaction of
WNV with Culex mosquito vectors. We ﬁrst examined whether
glycosylated and non-glycosylated viruses exhibited replicative differ-
ences in vitro and in vivo. We then examined whether WNV infectivity
and spread in vivo was affected by the presence or absence of a glycan
on the E protein. These are the ﬁrst studies to date examining how E
protein glycosylation affects WNV–vector relationships.
Results
Conﬁrmation of E protein glycan removal from WNV-N154I
To begin our studies of the effects of WNV E protein glycosyla-
tion, we made a recombinant virus in which the asparagine at aa154
was changed to an isoleucine (WNV-N154I), using a double-ected with WNV-WT or WNV-N154I at an MOI of 3 or 0.01, and samples of supernatant
oint are shown as log10 PFU/mL.
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likelihood of reversion. We then conﬁrmed that mutation of the E-
N154 residue resulted in a WNV with a non-glycosylated E protein.
Following peptide N-glycosidase F (PNGase F) digestion of the
WNV-WT E protein, a mobility shift was observed, consistent with
removal of the single N-linked glycan from the protein (Fig. 1, lanes
1 and 2). However, both the mock- and PNGase F-digested WNV-
N154I E proteins (lanes 3 and 4) migrated at the same position as
the PNGase F-digested WNV-WT E protein (lane 2), indicating that
the E-N154I substitution resulted in a non-glycosylated E protein.
Replicative ability of WNV-WT and WNV-N154I in cell culture
We ﬁrst examined whether the WNV-WT and WNV-N154I viruses
differed in their replication efﬁciencies and/or kinetics in vitro. At an
MOI of 3, both viruses replicated with similar kinetics and to similar
peak titers in mosquito cells (Fig. 2). However, in vertebrate cells,
WNV-WT replicated to titers up to1 log higher than those of WNV-
N154I. Similar results were obtained at an MOI of 0.01. There were no
detectable differences between the plaque phenotypes of WNV-WT
and WNV-N154I (data not shown).
Previous studies have suggested that WNV entry and release may
be affected by a lack of E protein glycosylation.We therefore compared
the ratios of genome copies per PFU for the glycosylated and non-
glycosylated viruses. WNV-N154I had more genome copies per PFU
(135) than WNV-WT (70, pb0.0001), suggesting that a signiﬁcantly
larger proportion of the viral particles produced by WNV-N154I are
non-infectious.
Replicative ability of WNV-WT and WNV-N154I in Culex mosquitoes
Adult female mosquitoes were inoculated with either WNV-WT or
WNV-N154I to determine whether E protein glycosylation affectedFig. 3. Viral replication of WNV-WT and WNV-N154I in Culex mosquitoes. Cx. pipiens
(A) and Cx. tarsalis (B) were intrathoracically inoculated with 10 PFU of eitherWNV-WT
or WNV-N154I and held for up to 10 days. At daily intervals, 10 mosquitoes per virus
were removed and the viral titers present in their bodies determined by plaque titration
on Vero cells. Mean viral titers from infected mosquitoes at each time point are shown
as log10 PFU/mosquito. LOD: limit of detection. ⁎: pb0.05.replicative ability in vivo. Titers in WNV-WT-inoculated mosquitoes
were signiﬁcantly higher than those inoculated with WNV-N154I
beginning at 1 day post-inoculation (pb0.05, Fig. 3). WNV-WT
reached similar peak titers in both Cx. pipiens and Cx. tarsalis, while
peak titers of WNV-N154I were signiﬁcantly higher in Cx. tarsalis than
in Cx. pipiens (p=0.037).
We also determined the replication efﬁciencies of WNV-WT and
WNV-N154I in mosquito midguts following peroral infection and
salivary glands following inoculation. We did not examine salivary
gland replication following feeding due to the potential midgut barrier
which would confound our salivary gland results. Viral loads in
midguts of Cx. pipiens exposed to WNV-WT were signiﬁcantly higher
at all time points than in those exposed to WNV-N154I (pb0.05,
Fig. 4A). In addition, the peak viral titer in WNV-WT-exposed
mosquitoes was signiﬁcantly greater than that of mosquitoes exposed
toWNV-N154I. Although both the viral loads and peak viral titer were
greater in midguts of Cx. tarsalis exposed to WNV-WT than in those
exposed to WNV-N154I, the differences were not statistically
signiﬁcant (Fig. 4B). Viral loads in the salivary glands of both species
were signiﬁcantly higher in mosquitoes infected with WNV-WT
(pb0.05, Figs. 4C, D).
Vector competence of Culex mosquitoes
To evaluate the impact of E protein glycosylation on the ability of
WNV to infect and spread within the mosquito vector following
peroral exposure, we examined the vector competence of Cx. pipiens
and Cx. tarsalis for WNV-WT and WNV-N154I. The infection rates and
body titers of WNV-WT were higher at 5, 7, and 9 days post-feeding
(dpf) than those of WNV-N154I in Cx. pipiens, with no signiﬁcant
difference observed at 14 dpf (Table 1 and data not shown). In Cx.
tarsalis, WNV-N154I was more infectious than WNV-WT at 5 and
14 dpf, while the infection rates were not signiﬁcantly different at 7
and 9 dpf (Table 2). Interestingly, the body titers of mosquitoes
infected with WNV-WT were signiﬁcantly higher than those infected
with WNV-N154 at all dpf (data not shown).
Dissemination rates were signiﬁcantly reduced in WNV-N154I-
infected mosquitoes at 9 and 14 dpf in Cx. pipiens (Table 1) and at all
dpf in Cx. tarsalis (Table 2). Transmission rates of mosquitoes infected
with WNV-N154I were reduced in both species, although the
difference between the viruses was only signiﬁcant at 14 dpf in Cx.
tarsalis. The total transmission rates over the entire experiment were
signiﬁcantly reduced in both species (Tables 1 and 2).
We sequenced a 500 bp region of the E genes of the viruses
present in all mosquitoes with disseminated infections that had fed
on WNV-N154I (n=26). In 20 mosquitoes, the viruses present in the
bodies and legs were the virus on which they fed, WNV-N154I (data
not shown). Five of these also had infectious virus in their salivary
secretions, and in all but one the virus had reverted to contain the
glycosylation site in the E protein (Table 3). Six mosquitoes contained
revertant viruses in either their legs or both their bodies and legs. One
of these mosquitoes also contained revertant virus in its salivary
secretions (Table 3).
Discussion
One of the more signiﬁcant sequence differences among WNV
strains is the presence or absence of an N-linked glycosylation site at
aa154–156 in the E protein. Previous work examining the potential
phenotypic effects of WNV E protein glycosylation has focused on in
vitro systems and mammalian infection models (Beasley et al., 2005;
Davis et al., 2006; Hanna et al., 2005; Li et al., 2006; Scherret et al.,
2001; Shirato et al., 2004, 2006). In the current study, we examined
whether glycosylation of the E protein affects WNV interactions with
mosquito vectors in vivo, using two mosquito species important for
enzootic viral transmission in the United States.
Fig. 4. Replication ofWNV-WTandWNV-N154I inmosquito tissues. (A and B) Viral replication inmosquitomidguts. Cx. pipiens (A) and Cx. tarsalis (B) were fed on deﬁbrinated goose
blood containing 108 PFU/mL of eitherWNV-WTorWNV-N154I and held for up to 10 days post-feeding. At the indicated time points, midguts were removed from 20mosquitoes per
virus and their viral titers determined by plaque titration on Vero cells. Mean viral titers from infected midguts at each time point are shown as log10 PFU/midgut. LOD: limit of
detection. ⁎: pb0.01. (C, D) Viral replication in mosquito salivary glands. Cx. pipiens (C) and Cx. tarsalis (D) were intrathoracically inoculated with 10 PFU of either WNV-WTorWNV-
N154I and held for up to 10 days. At the indicated time points, salivary glands were removed from 5–10mosquitoes per virus and their viral titers determined by plaque assay on Vero
cells. Mean viral titers from infected salivary gland pairs at each time point are shown as log10 PFU/SG pair. LOD: limit of detection. ⁎: pb0.01.
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recombinant WNVs, a virus containing the E protein glycosylation site
(WNV-WT) and a virus in which the glycosylation site had been
mutated (WNV-N154I), and detected no differences in either replica-
tion kinetics or peak virus titer in mosquito cells, although minor
differences were found in vertebrate cells (Fig. 2). This was
unexpected, as work by other groups had found that lack of
glycosylation decreased viral peak titer in mosquito cells in vitro by
at least 10-fold (Hanna et al., 2005; Li et al., 2006; Scherret et al.,
2001). However, the previous studies used either lineage 2 viruses or
Kunjin virus, which may explain the differences in our results.
As previous work from our laboratory has found that in vitro
results are not necessarily predictive of in vivo differences (Moudy
et al., 2007), all further work was done using an in vivo system. We
ﬁrst examined whether E protein glycosylation affected viral replica-
tion efﬁciency, either in whole mosquitoes or in individual mosquito
tissues. WNV-WT replicated more efﬁciently and to higher peak titers
thanWNV-N154I inwhole mosquitoes following inoculation (Figs. 3).
The differences between the viruses were more pronounced in Cx.Table 1
Vector competence of Culex pipiens following peroral infection
Days post
Virus 5 7
Ia D T I D T I D
WNV-WT 71 (n=80) 7 (n=57) 0 83 (n=77) 3 (n=64) 0 79 (n=77) 1
WNV-N154I 46 (n=90) 5 (n=41) 0 58 (n=90) 13b (n=48) 0b 68 (n=60) 2
P valuec 0.0007 0.735 1.00 0.0004 0.057 1.00 0.147 0
a I: % infected, D: % disseminated (of infected), T: % transmitting (of infected).
b Does not include mosquitoes with revertant virus.
c Calculated using χ2 test.pipiens (Fig. 3A) than in Cx. tarsalis (Fig. 3B), although in both cases
the differences in viral titers were signiﬁcant at all time points post-
infection. To examine replication in individual tissues, we used two
different methods of infection. Midgut replication was analyzed
following peroral infection, as WNV infection of the midgut in these
two Culex species is unidirectional and does not occur following
inoculation (Yongqing Jia, unpublished data). Replication in the
salivary glands was examined following intrathoracic inoculation, to
ensure that any potential barriers tomidgut infection or egress did not
confound the salivary gland results. Analysis of replication in both
tissues gave similar results, in that WNV-WT replicated more
efﬁciently thanWNV-N154I (Fig. 4), although the differences between
the viral titers in mosquito midguts were only signiﬁcant in Cx.
pipiens. These data indicate that glycosylation of the WNV E protein is
important for efﬁcient replication within the mosquito. However,
there are apparently species- or colony-speciﬁc differences in how
glycosylation affects WNV interaction with the mosquito vector.
Mosquito colony- and species-speciﬁc differences in infectivity,
replication efﬁciency, and vector competence have previously been-feeding
9 14 Total
T I D T I D T
5 (n=61) 5 49 (n=67) 36 (n=33) 12 71 (n=301) 12 (n=215) 3
(n=41) 0 51 (n=43) 2 (n=22) 0b 54 (n=283) 7b (n=152) 0b
.040 0.272 0.845 0.007 0.141 b0.0001 0.105 0.045
Table 2
Vector competence of Culex tarsalis following peroral infection
Days post-feeding
Virus 5 7 9 14 Total
Ia D T I D T I D T I D T I D T
WNV-WT 25(n=150) 14(n=37) 0 31(n=150) 30(n=47) 9 22(n=130) 50(n=28) 14 21(n=98) 76(n=21) 52 25(n=528) 37(n=133) 14
WNV-
N154I
42(n=130) 2b(n=54) 0 30(n=130) 0b(n=39) 0b 29(n=130) 8b (n=38) 3b 34(n=115) 26(n=39) 0 34(n=505) 9b(n=172) 0.06b
P valuec 0.003 0.028 1.00 0.809 0.0002 0.062 0.154 0.0001 0.077 0.044 0.0002 b0.0001 0.003 b0.0001 b0.0001
a I: % infected, D: % disseminated (of infected), T: % transmitting (of infected).
b Does not include mosquitoes with revertant virus.
c Calculated using χ2 test.
226 R.M. Moudy et al. / Virology 387 (2009) 222–228noted for several ﬂaviviruses (Kramer and Ebel, 2003); it is therefore
not entirely surprising that we observed them in our studies. Future
work examining potential mechanistic differences between glycosy-
lated and non-glycosylated WNV in different mosquito colonies and
species should yield additional information regarding the effects of E
protein glycosylation on WNV interaction with mosquito vector
species.
We next examined how vector competence was affected by E
protein glycosylation. These studies examine the ability of the virus to
not only infect the mosquito following feeding on an infectious
bloodmeal, but also to disseminate from the midgut and eventually be
transmitted to a new host. Overall in Cx. pipiens, WNV-WT infected a
higher proportion of mosquitoes than WNV-N154I, while the reverse
was true in Cx. tarsalis (Tables 1 and 2), again suggesting species- or
colony-speciﬁc differences in virus–vector interactions. Our observa-
tions in Cx. tarsalis were particularly interesting, in that although a
larger proportion of mosquitoes were infected following feeding on
WNV-N154I, their bodies and midguts contained signiﬁcantly less
virus than mosquitoes that fed on WNV-WT. These results suggest
that the presence or absence of the E protein glycan differentially
affects multiple steps in the viral replication cycle.
Other members of the Flaviviridae, such as TBEV and DENV, also
contain at least one glycosylation site in the E protein. DENV normally
contains two glycans on its E protein (aa67 and aa153), and removal of
the aa67 glycosylation site severely inhibited growth in vitro, but not
in vivo in mosquitoes (Bryant et al., 2007). DENV mutants lacking
the glycosylation site at aa153 were found to induce fusion at a higher
pH thanWT DENV (Guirakhoo et al., 1993; Lee et al., 1997). It has been
suggested that carbonic anhydrase (CA) plays a role in maintenance of
midgut pH. CA is active to varying extents in the midguts of different
species, with the highest activity found in Ae. aegypti and the lowest in
Cx. quinquefaciatus (del Pilar et al., 2005). These studies have shown
that mosquito midgut pH varies between species, with the pH of Cx.
tarsalis midguts ranging from 8.0–9.5 (del Pilar et al., 2005). If the
glycan at aa154 has a similar effect on the pH threshold of fusion as has
been observed previously for the DENV aa153 glycan, it would be
expected that a mosquito with a higher midgut pH could be moreTable 3
Analysis of WNV reversion in mosquito bodies, legs, and salivary secretionsa
Mosquito species Days post-feeding Input Body Legs Salivary secretionsb
Cx. pipiens 7 ATA ATA ATA AAC
7 ATA ATA ATA AAC
7 ATA ATA/AAC AAC –
7 ATA AAC AAC –
14 ATA ATA ATA AAC
Cx. tarsalis 7 ATA ATA AAC –
7 ATA ATA AAC AAC
9 ATA ATA ATA ATA
9 ATA ATA ATA AAC
a Only mosquitoes with revertant virus in at least one tissue are shown, out of a total
of 9 Cx pipiens and 17 Cx tarsalis tested from 5–14 dpf.
b –: not transmitting.easily infected by WNV lacking the aa154 glycan. Unfortunately, the
midgut pH range of Cx. pipiens has not been determined; however, it is
interesting to speculate that the differences we observed in infection
and midgut replication between mosquito species are the result of Cx.
tarsalis having a higher midgut pH than Cx. pipiens. As midgut pH
would be expected to affect only the initial steps of the viral
replication cycle, binding and entry, this also could explain the
apparent discrepancy between infection rate and virus titers that we
observed in Cx. tarsalis.
In both mosquito species, a signiﬁcantly lower proportion of
mosquitoes that fed onWNV-N154I had virus present in their legs and
salivary glands. Additionally, in ﬁve out of the six mosquitoes that
transmitted WNV following feeding on WNV-N154I, the virus present
in the salivary secretions contained the glycosylation site, indicating
that the virus had reverted to aWTglycosylation phenotype (Table 3).
The reversions appear to have occurred at multiple points during
WNV spread throughout the mosquito, as we found revertant viruses
in the salivary secretions and/or legs without reversion in the
mosquito body. As reversion at the glycosylation site had not
previously been observed during viral replication in either vertebrate
or mosquito cells in vitro (data not shown), these data suggest that not
only is E protein glycosylation important for efﬁcient WNV spread
throughout the mosquito, but that there is strong selective pressure
toward glycosylation at aa154 in transmitted viruses. However, E
protein glycosylation alone is not sufﬁcient to ensure transmission, as
three mosquitoes with revertant viruses in their bodies and/or legs
did not have infectious virus present in their salivary secretions. This is
not surprising, as there is not a 100% transmission rate for mosquitoes
feeding on WNV-WT (Tables 1 and 2).
One caveat to our ﬁndings is that we have examined the effect of
only a single amino acid change out of several possible mutations that
would be predicted to remove the glycosylation site. Other groups
examining WNV E protein glycosylation have utilized different
mutations to remove the N154 glycosylation site, such as Q154 and
S154. In mice, similar phenotypes were obtained regardless of the
speciﬁc amino acid change (Beasley et al., 2005; Shirato et al., 2004).
Therefore, we do not expect that our results are due to the presence of
an isoleucine at position 154, rather than the lack of the N154 glycan;
however, work is currently underway to examine this possibility.
Although we did not ﬁnd a signiﬁcant difference in the titers of our
recombinant virus stocks following recovery in BHK cells, there were
nearly twice as many uninfectious particles in the WNV-N154I virus
stock as in theWNV-WT virus stock. These data suggest that the N154I
mutation inhibits infectious WNV particle production. Hanna et al.
(2005) found that non-glycosylated WNV was more infectious for
mammalian, avian, and mosquito cells than glycosylated WNV, when
the viruses were normalized to genome equivalents. Our data appear
to conﬂict with these ﬁndings; however, our study examined the
production of infectious particles (PFU), while the previous study
deﬁned infectivity as viral entry and initial rounds of replication.
When virus production was measured, Hanna et al. observed a
signiﬁcant decrease in viruses lacking the E glycan, similar to our
227R.M. Moudy et al. / Virology 387 (2009) 222–228study. Therefore, the difference in infectivity results is likely due to the
difference in experimental design. Work with TBEV also found
decreased VLP production when the glycan at E154 was removed
(Goto et al., 2005), suggesting that this phenotype is common among
the ﬂaviviruses. Future experiments will examine whether the defect
in infectivity we observed is due to decreased efﬁciency of entry into
host cells, a defect in prM-E association leading to a decrease in
packaging efﬁciency, or a combination of factors.
Materials and methods
Cells and mosquitoes
Baby hamster kidney (BHK) cells were used for viral growth. Aedes
albopictus (C6/36), chick embryonic ﬁbroblast (DF-1), and African
green monkey kidney (Vero) cells were used for in vitro replication
analyses. Viruses were titrated on Vero cells. All experiments
involving infectious WNV were performed in the Wadsworth Center
Arbovirus Laboratories' BSL3 laboratory.
Cx. pipiens and Cx. tarsalismosquitoeswere derived from laboratory
colonies. The Cx. pipiens colony originated in 2002 from egg rafts
collected in Pennsylvania, and the Cx. tarsalis colony originated in 2003
from egg rafts collected in the Coachella Valley in California. Colonized
mosquitoesweremaintained on goose blood (for egg laying) and given
10% sucrose ad libitum. Larvae were reared and adults maintained
under controlled conditions of temperature (27 °C), humidity (70%
RH), and light (16:8 L:D diurnal cycle), in 12q×12q×12q cages. All
mosquito experiments involving infectious WNV were carried out in
the Arbovirus Laboratories' BSL3 insectary.
Construction of mutant WNV cDNA and recovery of infectious viruses
A mutant cDNA plasmid of full-length lineage I WNV, in which the
asparagine at amino acid 154 in the E protein was replaced with an
isoleucine, was constructed using a modiﬁed infectious cDNA clone,
pFLWNV (Shi et al., 2002b), and a shuttle vector including the entire E
gene sequence. The glycosylation site mutation was ﬁrst made in the
shuttle vector using an overlapping PCR-mediated mutagenesis
method. The mutation was conﬁrmed by DNA sequencing prior to
transfer of the shuttle vector sequence into pFLWNV. The mutated
pFLWNV sequence was also conﬁrmed by DNA sequencing.
To recover infectious viruses with from the WT and mutant
pFLWNV plasmids, genome-length RNAs were in vitro transcribed and
transfected into BHK cells (Shi et al., 2002a). Cell supernatants
containing WNV were harvested at 96 h post-transfection and their
titers determined by plaque assay on Vero cells. Titers of virus
recovered from theWT pFLWNV, henceforth calledWNV-WT, were 2–
4×109 PFU/mL. Titers of virus recovered from the mutant pFLWNV,
henceforth called WNV-N154I, were 2×109 PFU/mL.
Viral protein analysis
Viral E protein glycosylation states were determined essentially as
previously described (Hanna et al., 2005). Brieﬂy, WNV-WT and
WNV-N154I were inactivated at 56 °C for 1 h, and aliquots of each
virus were digested with 500 U of peptide N-glycosidase F (PNGase F,
New England Biolabs) for 1 h at 37 °C or mock digested as a negative
control. Samples were then analyzed by reducing SDS-PAGE and
Western blotting using an anti-E monoclonal Ab (MAb 5H10,
BioReliance). E proteins were visualized using WesternBreeze (Invi-
trogen), according to the manufacturer's instructions.
Viral replication in vitro
Viral replication was analyzed as previously described (Moudy
et al., 2007). Brieﬂy, WNV-WT and WNV-N154I were inoculated ontoDF-1, C6/36, and Vero cells at anMOI of 0.01 or 3 and virus production
examined over a period of up to 120 h post-infection. Viral titers at
each time point were determined by plaque titration on Vero cells.
Genome copy number determination
RNAwas isolated from 108 PFU of WNV-WT andWNV-N154I using
the RNeasy mini kit (Qiagen) and viral genome copy number was
measured by real-time RT-PCR (7500 RT PCR system, Applied
Biosystems) using a primer/probe set targeting the E gene (Shi et
al., 2001). Full-length RNA transcribed from an infectious cDNA clone
of WNV was used as a reference for the quantitation of the real-time
RT-PCR (Shi et al., 2002b). Genome copy number to PFU ratios were
determined for six replicates from each virus and compared using
a t-test.
Viral replication in Culex mosquitoes
WNV-WT and WNV-N154I were diluted in mosquito diluent (MD:
20% heat-inactivated FBS in Dulbecco's phosphate-buffered saline plus
50 μg/mL penicillin/streptomycin, 50 μg/mL gentamicin and 2.5 μg/
mL fungizone) to a titer of 105 PFU/mL. Mosquitoes (b5 days old)
were inoculated intrathoracically with 10 PFU of either WNV-WT or
WNV-N154I under CO2 anesthesia and held at 27 °C, 16:8 light:dark
photoperiod for up to 10 days post-inoculation. At daily intervals from
0 to 10 days post-inoculation, 10 mosquitoes inoculated with each
virus were removed to individual aliquots of 1 mL MD. All samples
were stored at−80 °C. Mosquitoes were homogenized in a mixer mill
(Qiagen) and clariﬁed by centrifugation. The viral loads of infected
mosquitoes were determined by plaque titration on Vero cells and
compared using ANOVA.
Vector competence of Culex mosquitoes
Five to 7 day old adult femalemosquitoes were deprived of sucrose
for 48 h prior to feeding. WNV-WT and WNV-N154I were added to
5 mL deﬁbrinated goose blood with 2.5% sucrose to a ﬁnal titer of 108
PFU/mL. Mosquitoes were fed for 1 to 2 h using a Hemotekmembrane
feeding apparatus (DiscoveryWorkshops, Accrington, UK), as directed
by the manufacturer. Following feeding, fully engorged mosquitoes
were separated under CO2 anesthesia to 0.5 L cartons, supplied with
10% sucrose ad lib, and held at 27 °C, 16:8 L:D photoperiod for up to
14 days post-feeding.
Transmission was evaluated in vitro, essentially as previously
described (Aitken, 1977). Brieﬂy, mosquitoes were anesthetized with
triethylamine (Sigma, St. Louis, MO), and their legs removed into 1 mL
MD. Mosquito mouthparts were placed into a capillary tube containing
approximately 10 μL of a 1:1 mixture of FBS and 50% sucrose for
approximately 30 min, after which time the contents of the capillary
tube were expelled into 0.3 mL MD. Mosquito bodies were placed into
1 mL MD, and all samples were stored at−80 °C. Mosquito bodies and
legs were homogenized in a mixer mill (Qiagen) and clariﬁed by
centrifugation. The proportion of mosquitoes with infected bodies, legs,
and salivary secretions was determined by plaque assay on Vero cells.
Infection, dissemination, and transmission were deﬁned as the propor-
tion of mosquitoes with infected bodies, legs, and salivary secretions,
respectively. Proportions were compared using Chi square analysis.
Viral replication in mosquito midguts
Five to 7 day old adult female mosquitoes were infected perorally
with either WNV-WT or WNV-N154I, as described above. Following
feeding, fully engorged mosquitoes were held at 27 °C, 16:8 L:D
photoperiod for up to 10 days post-feeding. At 2, 4, 6, 8, and 10 days
post-feeding, midguts from 20 mosquitoes per virus were removed,
washed in MD to remove blood and/or hemolymph, and individually
228 R.M. Moudy et al. / Virology 387 (2009) 222–228stored in 0.5 mL MD at −80 °C. Midguts were homogenized using a
mixer mill (Qiagen) and clariﬁed by centrifugation. The viral loads of
infected midguts were determined by plaque titration on Vero cells
and compared using ANOVA.
Viral replication in mosquito salivary glands
Mosquitoes (b5 days old) were intrathoracically inoculated with
eitherWNV-WTorWNV-N154I, as described above, and held for up to
10 days post-inoculation. At 2, 4, 6, 8, and 10 days post-inoculation,
salivary glands from 10 mosquitoes per virus were removed, washed
in MD to remove hemolymph, and individually stored in 0.5 mL MD at
−80 °C. Salivary glands were homogenized using a mixer mill
(Qiagen) and clariﬁed by centrifugation. Viral loads of infected
salivary glands were determined by plaque titration on Vero cells
and compared using ANOVA.
Sequencing of mosquito-derived viruses
Viral genomic RNA was puriﬁed from infected bodies, legs, and
salivary secretions of mosquitoes that fed on WNV-N154I using
RNeasy spin columns (Qiagen) according to the manufacturer's
instructions. One-step RT-PCR (Qiagen) was performed using primers
designed to amplify the 500 bp region of the envelope gene
surrounding the glycosylation site (nt1208–1700). PCR products
were puriﬁed (Qiagen) and visualized on 1% agarose gels. Automated
sequencing of puriﬁed PCR products was performed at theWadsworth
Center Applied Genomics Technology Core.
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